Latest filing published 14 Jan 2022 for Werewolf Therapeutics, Inc., €33k.
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Cynthia Seidel-Dugan: trading record in brief
All filings by Cynthia Seidel-Dugan on record concern Werewolf Therapeutics, Inc., in the capacity of senior executive. Activity is concentrated on a single trading day, 12 January 2022, with 2 filings.
Not one of the filings records a straightforward purchase or sale on the market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
Most recently, on 14 January 2022, the filings show an option exercise worth €65k in Werewolf Therapeutics, Inc. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Cynthia Seidel-Dugan
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 24,199 shares@ US$1.56100.0% of flowCommon StockSEC:0000899243-22-002027:0
1 of 1 declaration
